Home › Funds › John Hancock › Capital Appreciation Value Trust
Fund family: John Hancock · Filed by JOHN HANCOCK VARIABLE INSURANCE TRUST (CIK 756913) · SEC series S000021933
Share classes and tickers: JAFPX (C000063027), JAFQX (C000063028), JAFRX (C000063026)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 610 with, 68 against, 9 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 9 FOR, 60 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as John Hancock’s manager page (290,519 ballot items across 99 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | John Hancock | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 95.7% | 601 | 90.1% | 242,172 |
| Backed environmental and social shareholder proposals at US companies | n/a | 44 | 13.4% | 1,935 |
Each ballot item this fund voted is set against the votes of the other John Hancock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most John Hancock funds on 34 items (5.3% of the 647 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most John Hancock funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| APPLE INC. | 2026-02-24 | The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Andrea Jung | Against | FOR — 27 of 27 John Hancock funds | Against | — |
| ARISTA NETWORKS, INC. | 2026-05-29 | Approval, on an advisory basis, of the compensation of our named executive officers. | For | AGAINST — 10 of 11 John Hancock funds | For | Approved, 60.4% support |
| ALNYLAM PHARMACEUTICALS, INC. | 2026-05-20 | To elect the following nominees as Class I directors of Alnylam: Stuart A. Arbuckle | Against | FOR — 6 of 6 John Hancock funds | Against | Elected, 95.8% support |
| META PLATFORMS, INC. | 2026-05-27 | DIRECTOR: Robert M. Kimmitt | Abstain | FOR — 19 of 24 John Hancock funds | Against | — |
| S&P GLOBAL INC. | 2026-05-20 | Shareholder Vote on a shareholder proposal to reduce the stock ownership threshold for calling a special shareholder meeting; | Against | FOR — 9 of 10 John Hancock funds | For | Failed (calculated), 40.8% support |
| REVVITY, INC. | 2026-04-28 | Shareholder To approve the shareholder proposal regarding Executives to Retain Significant Stock. | Against | FOR — 9 of 10 John Hancock funds | For | Failed (calculated), 23.1% support |
| BROADCOM INC | 2026-04-20 | Advisory vote to approve the named executive officer compensation. | For | AGAINST — 15 of 19 John Hancock funds | For | Approved, 66.4% support |
| VISA INC. | 2026-01-27 | To elect the eleven director nominees named in the proxy statement. William Ready | Against | FOR — 12 of 15 John Hancock funds | Against | — |
| DOORDASH, INC. | 2026-06-10 | The election of the following director nominee(s): Milan Kovac | Against | FOR — 9 of 11 John Hancock funds | Against | Elected, 96.9% support |
| YUM! BRANDS, INC. | 2026-05-14 | Shareholder Shareholder Proposal to Reduce the Percentage of Shares Required to Call a Special Meeting. | Against | FOR — 6 of 7 John Hancock funds | For | Not approved, 37.7% support |
| CENTERPOINT ENERGY, INC. | 2026-04-16 | Approve CenterPoint Energy, Inc.'s Amended and Restated Certificate of Formation to provide for limited officer exculpation and make certain other immaterial updates. | For | AGAINST — 8 of 10 John Hancock funds | For | Approved, 60.7% support |
| CONOCOPHILLIPS | 2026-05-12 | Shareholder Stockholder Proposal - Independent Board Chairman. | Against | FOR — 9 of 12 John Hancock funds | For | Not approved, 28.0% support |
| CYTOKINETICS, INCORPORATED | 2026-05-27 | Election of Class I Directors for terms expiring in 2029. Wendell Wierenga, Ph.D. | Withhold | FOR — 7 of 9 John Hancock funds | Against | — |
| ALNYLAM PHARMACEUTICALS, INC. | 2026-05-20 | To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D. | Against | FOR — 5 of 6 John Hancock funds | Against | Elected, 89.3% support |
| AURORA INNOVATION, INC. | 2026-05-21 | Election of Directors Gloria Boyland | For | WITHHOLD — 3 of 3 John Hancock funds | For | — |
| VISA INC. | 2026-01-27 | Shareholder Shareholder proposal on shareholder right to act by written consent. | Against | FOR — 10 of 15 John Hancock funds | For | Not approved, 33.0% support |
| NETFLIX, INC. | 2026-06-04 | Shareholder Stockholder proposal entitled, "Proposal 4 - Shareholder Right to Act by Written Consent," if properly presented at the meeting. | Against | FOR — 7 of 10 John Hancock funds | For | Not approved, 44.6% support |
| ALPHABET INC. | 2026-06-05 | Advisory vote to approve compensation awarded to named executive officers | For | AGAINST — 16 of 29 John Hancock funds | For | Approved, 81.1% support |
| MASTERCARD INCORPORATED | 2026-06-16 | Shareholder Consideration of a stockholder proposal regarding shareholder right to act by written consent | Against | FOR — 8 of 13 John Hancock funds | For | Not approved, 30.1% support |
| VAXCYTE, INC. | 2026-06-15 | DIRECTOR: Halley Gilbert, J.D. | For | ABSTAIN — 5 of 8 John Hancock funds | For | — |
| VAXCYTE, INC. | 2026-06-15 | DIRECTOR: Olivier Brandicourt MD | For | ABSTAIN — 5 of 8 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Bruce Booth, D.Phil. | For | ABSTAIN — 4 of 6 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Elena Ridloff, CFA | For | ABSTAIN — 4 of 6 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: John Maraganore, Ph.D. | For | ABSTAIN — 4 of 6 John Hancock funds | For | — |
| KYMERA THERAPEUTICS, INC. | 2026-06-24 | DIRECTOR: Nello Mainolfi, Ph.D. | For | ABSTAIN — 4 of 6 John Hancock funds | For | — |
| Company | Meeting | Item | This fund | Most John Hancock funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| ADVANCED MICRO DEVICES, INC. | 2026-05-13 | Shareholder Stockholder proposal requesting changes to the stockholder right to call a special meeting. | Against | FOR — 5 of 9 John Hancock funds | For | Not approved, 37.5% support |
| CG ONCOLOGY, INC. | 2026-06-04 | To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Victor Tong, Jr. | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| ERASCA, INC. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Alexander W. Casdin | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| ERASCA, INC. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Julie Hambleton, M.D. | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| ERASCA, INC. | 2026-06-26 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified Michael D. Varney, Ph.D. | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| DYNE THERAPEUTICS, INC. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. David Lubner | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| DYNE THERAPEUTICS, INC. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. Jason Rhodes | For | WITHHOLD — 3 of 5 John Hancock funds | For | — |
| APOGEE THERAPEUTICS, INC. | 2026-06-09 | DIRECTOR: William (BJ) Jones, Jr. | For | ABSTAIN — 3 of 5 John Hancock funds | For | — |
| AURORA INNOVATION, INC. | 2026-05-21 | Election of Directors Michelangelo Volpi | For | WITHHOLD — 2 of 3 John Hancock funds | For | — |
Download all 34 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 93.7% of this fund’s 687 such votes could be given a sector; the other 43 (6.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Technology | 181 | 34 | 18.8% |
| Health Care | 137 | 3 | 2.2% |
| Consumer Discretionary | 106 | 20 | 18.9% |
| Finance | 63 | 6 | 9.5% |
| Utilities | 54 | 0 | 0.0% |
| Energy | 46 | 4 | 8.7% |
| Industrials | 40 | 1 | 2.5% |
| Consumer Staples | 12 | 0 | 0.0% |
| Telecommunications | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 473 | 1 |
| Audit-related | 55 | 0 |
| Say-on-Pay | 54 | 1 |
| Corporate Governance | 28 | 15 |
| Other Social Issues | 20 | 20 |
| Human Rights or Human Capital/workforce | 16 | 16 |
| Capital Structure | 12 | 0 |
| Compensation | 12 | 1 |
| Environment or Climate | 7 | 7 |
| Shareholder Rights and Defenses | 6 | 4 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| MICROSOFT CORPORATION | December 5, 2025 | $28M | 21 | 6 |
| AMAZON.COM, INC. | May 20, 2026 | $27M | 17 | 4 |
| APPLE INC. | February 24, 2026 | $26M | 12 | 1 |
| META PLATFORMS, INC. | May 27, 2026 | $20M | 23 | 10 |
| ADVANCED MICRO DEVICES, INC. | May 13, 2026 | $18M | 12 | 1 |
| REVVITY, INC. | April 28, 2026 | $16M | 14 | 1 |
| BECTON, DICKINSON AND COMPANY | January 27, 2026 | $14M | 16 | 0 |
| NVIDIA CORPORATION | June 24, 2026 | $13M | 16 | 4 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| December 5, 2025 | MICROSOFT CORPORATION | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | MICROSOFT CORPORATION | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 20, 2026 | AMAZON.COM, INC. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | AMAZON.COM, INC. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| February 24, 2026 | APPLE INC. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| May 27, 2026 | META PLATFORMS, INC. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | For | Against |
| May 27, 2026 | META PLATFORMS, INC. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 13, 2026 | ADVANCED MICRO DEVICES, INC. | Stockholder proposal requesting changes to the stockholder right to call a special meeting. Shareholder proposal | Against | For |
| April 28, 2026 | REVVITY, INC. | To approve the shareholder proposal regarding Executives to Retain Significant Stock. Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA CORPORATION | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA CORPORATION | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| June 5, 2026 | ALPHABET INC. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
These funds reported the same votes as Capital Appreciation Value Trust in the latest season, so they share this page:
689 ballot items at 56 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Capital Appreciation Value Trust (JAFPX) voted at 56 shareholder meetings of 56 companies, on 689 ballot items in all. Where management made a recommendation, the fund followed it on 88.8% of the items and voted against it 68 times. Its most frequent area of disagreement was other social issues (20 of its votes against management). It voted FOR 13.0% of the 69 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than John Hancock's funds as a whole (95.7% against 90.1%). It voted differently from most John Hancock funds on 34 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of John Hancock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.